{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:32:15Z","timestamp":1783996335585,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/hr.2013.69","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T08:05:25Z","timestamp":1375689925000},"page":"657-660","source":"Crossref","is-referenced-by-count":42,"title":["Salt, the renin\u2013angiotensin\u2013aldosterone system and resistant hypertension"],"prefix":"10.1038","volume":"36","author":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,5]]},"reference":[{"key":"BFhr201369_CR1","first-page":"3","volume":"32","author":"T Ogihara","year":"2009","unstructured":"Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H . The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32: 3\u2013107.","journal-title":"Hypertens Res"},{"key":"BFhr201369_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jama.290.2.199","volume":"290","author":"I Hajjar","year":"2003","unstructured":"Hajjar I, Kotchen TA . Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988\u20132000. JAMA 2003; 290: 199\u2013206.","journal-title":"JAMA"},{"key":"BFhr201369_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","volume":"4","author":"WC Cushman","year":"2002","unstructured":"Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, Black HR, Hamilton BP, Holland J, Nwachuku C, Papademetriou V, Probstfield J, Wright JT Jr, Alderman MH, Weiss RJ, Piller L, Bettencourt J, Walsh SM . Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002; 4: 393\u2013404.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"BFhr201369_CR4","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","volume":"289","author":"HR Black","year":"2003","unstructured":"Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ . Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003; 289: 2073\u20132082.","journal-title":"JAMA"},{"key":"BFhr201369_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","volume":"49","author":"N Chapman","year":"2007","unstructured":"Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, Poulter NR . Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 2007; 49: 839\u2013845.","journal-title":"Hypertension"},{"key":"BFhr201369_CR6","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","volume":"51","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM . Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51: 1403\u20131419.","journal-title":"Hypertension"},{"key":"BFhr201369_CR7","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1097\/00004872-200111000-00018","volume":"19","author":"C Cuspidi","year":"2001","unstructured":"Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, Severgnini B, Meani S, Magrini F, Zanchetti A . High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 2001; 19: 2063\u20132070.","journal-title":"J Hypertens"},{"key":"BFhr201369_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","volume":"168","author":"KK Gaddam","year":"2008","unstructured":"Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S, Calhoun DA . Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med 2008; 168: 1159\u20131164.","journal-title":"Arch Intern Med"},{"key":"BFhr201369_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0002-8703(78)90303-4","volume":"95","author":"S Shah","year":"1978","unstructured":"Shah S, Khatri I, Freis ED . Mechanism of antihypertensive effect of thiazide diuretics. Am Heart J 1978; 95: 611\u2013618.","journal-title":"Am Heart J"},{"issue":"11 Pt 1","key":"BFhr201369_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"MK Nishizaka","year":"2003","unstructured":"Nishizaka MK, Zaman MA, Calhoun DA . Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 2003; 16 (11 Pt 1): 925\u2013930.","journal-title":"Am J Hypertens"},{"key":"BFhr201369_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1524-6175.2004.03412.x","volume":"6","author":"MK Nishizaka","year":"2004","unstructured":"Nishizaka MK, Calhoun DA . Use of aldosterone antagonists in resistant hypertension. J Clin Hypertens (Greenwich) 2004; 6: 458\u2013460.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"BFhr201369_CR12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/nm.2891","volume":"18","author":"A McCurley","year":"2012","unstructured":"McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ . Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med 2012; 18: 1429\u20131433.","journal-title":"Nat Med"},{"key":"BFhr201369_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/HJH.0b013e32835b71d6","volume":"31","author":"PM Jansen","year":"2013","unstructured":"Jansen PM, Frenkel WJ, van den Born BJ, de Bruijne EL, Deinum J, Kerstens MN, Arnoldus JH, Woittiez AJ, Wijbenga JA, Zietse R, Danser AH, van den Meiracker AH . Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension. J Hypertens 2013; 31: 404\u2013413.","journal-title":"J Hypertens"},{"key":"BFhr201369_CR14","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1210\/en.2006-0944","volume":"147","author":"C Guo","year":"2006","unstructured":"Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK . Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology 2006; 147: 5363\u20135373.","journal-title":"Endocrinology"},{"key":"BFhr201369_CR15","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1210\/en.2007-1770","volume":"149","author":"N Oyamada","year":"2008","unstructured":"Oyamada N, Sone M, Miyashita K, Park K, Taura D, Inuzuka M, Sonoyama T, Tsujimoto H, Fukunaga Y, Tamura N, Itoh H, Nakao K . The role of mineralocorticoid receptor expression in brain remodeling after cerebral ischemia. Endocrinology 2008; 149: 3764\u20133777.","journal-title":"Endocrinology"},{"key":"BFhr201369_CR16","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.105.539122","volume":"112","author":"M Quinkler","year":"2005","unstructured":"Quinkler M, Zehnder D, Eardley KS, Lepenies J, Howie AJ, Hughes SV, Cockwell P, Hewison M, Stewart PM . Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation 2005; 112: 1435\u20131443.","journal-title":"Circulation"},{"key":"BFhr201369_CR17","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1172\/JCI43124","volume":"121","author":"S Shibata","year":"2011","unstructured":"Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, Kawarazaki W, Takeuchi M, Ayuzawa N, Miyoshi J, Takai Y, Ishikawa A, Shimosawa T, Ando K, Nagase M, Fujita T . Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest 2011; 121: 3233\u20133243.","journal-title":"J Clin Invest"},{"key":"BFhr201369_CR18","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T . Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14: 1370\u20131376.","journal-title":"Nat Med"},{"key":"BFhr201369_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1126\/science.290.5489.144","volume":"290","author":"AR Simon","year":"2000","unstructured":"Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, Guan KL . Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 2000; 290: 144\u2013147.","journal-title":"Science"},{"key":"BFhr201369_CR20","doi-asserted-by":"publisher","first-page":"H2516","DOI":"10.1152\/ajpheart.00299.2003","volume":"285","author":"H Wang","year":"2003","unstructured":"Wang H, Huang BS, Leenen FH . Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension. Am J Physiol Heart Circ Physiol 2003; 285: H2516\u2013H2523.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr201369_CR21","doi-asserted-by":"publisher","first-page":"H1067","DOI":"10.1152\/ajpheart.01131.2007","volume":"294","author":"ZH Zhang","year":"2008","unstructured":"Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB . Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol 2008; 294: H1067\u2013H1074.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr201369_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.112.196576","volume":"60","author":"B Xue","year":"2012","unstructured":"Xue B, Zhang Z, Roncari CF, Guo F, Johnson AK . Aldosterone acting through the central nervous system sensitizes angiotensin II-induced hypertension. Hypertension 2012; 60: 1023\u20131030.","journal-title":"Hypertension"},{"key":"BFhr201369_CR23","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/hr.2011.220","volume":"35","author":"T Nakagaki","year":"2012","unstructured":"Nakagaki T, Hirooka Y, Matsukawa R, Nishihara M, Nakano M, Ito K, Hoka S, Sunagawa K . Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats. Hypertens Res 2012; 35: 470\u2013476.","journal-title":"Hypertens Res"},{"key":"BFhr201369_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/hr.2012.174","volume":"36","author":"M Nakano","year":"2012","unstructured":"Nakano M, Hirooka Y, Matsukawa R, Ito K, Sunagawa K . Mineralocorticoid receptors\/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats. Hypertens Res 2012; 36: 277\u2013284.","journal-title":"Hypertens Res"},{"key":"BFhr201369_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/01.HYP.0000165690.85505.37","volume":"45","author":"M Fujita","year":"2005","unstructured":"Fujita M, Kuwaki T, Ando K, Fujita T . Sympatho-inhibitory action of endogenous adrenomedullin through inhibition of oxidative stress in the brain. Hypertension 2005; 45: 1165\u20131172.","journal-title":"Hypertension"},{"key":"BFhr201369_CR26","doi-asserted-by":"publisher","first-page":"E425","DOI":"10.1152\/ajpendo.00227.2011","volume":"302","author":"F Kawakami-Mori","year":"2012","unstructured":"Kawakami-Mori F, Shimosawa T, Wang H, Ogura S, Mu S, Yatomi Y, Fujita T . NADPH oxidase-mediated Rac1 GTP activity is necessary for non-genomic actions of the mineralocorticoid receptor in the CA1 region of the rat hippocampus. Am J Physiol Endocrinol Metab 2012; 302: E425\u2013E432.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFhr201369_CR27","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1097\/HJH.0b013e3283576904","volume":"30","author":"H Kawarazaki","year":"2012","unstructured":"Kawarazaki H, Ando K, Shibata S, Muraoka K, Fujita M, Kawarasaki C, Fujita T . Mineralocorticoid receptor-Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats. J Hypertens 2012; 30: 1977\u20131985.","journal-title":"J Hypertens"},{"key":"BFhr201369_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2012.10.549","volume":"54","author":"N Queisser","year":"2013","unstructured":"Queisser N, Amann K, Hey V, Habib SL, Schupp N . Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo. Free Radic Biol Med 2013; 54: 17\u201325.","journal-title":"Free Radic Biol Med"},{"key":"BFhr201369_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2013","unstructured":"Briet M, Schiffrin EL . Vascular actions of aldosterone. J Vasc Res 2013; 50: 89\u201399.","journal-title":"J Vasc Res"},{"key":"BFhr201369_CR30","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/hr.2010.159","volume":"33","author":"AA Zia","year":"2010","unstructured":"Zia AA, Kamalov G, Newman KP, McGee JE, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT . From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation. Hypertens Res 2010; 33: 1091\u20131101.","journal-title":"Hypertens Res"},{"key":"BFhr201369_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/HYPERTENSIONAHA.112.194787","volume":"60","author":"P Raheja","year":"2012","unstructured":"Raheja P, Price A, Wang Z, Arbique D, Adams-Huet B, Auchus RJ, Vongpatanasin W . Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients. Hypertension 2012; 60: 319\u2013325.","journal-title":"Hypertension"},{"key":"BFhr201369_CR32","doi-asserted-by":"publisher","first-page":"17985","DOI":"10.1073\/pnas.0605545103","volume":"103","author":"SD Crowley","year":"2006","unstructured":"Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM . Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 2006; 103: 17985\u201317990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr201369_CR33","doi-asserted-by":"publisher","first-page":"F965","DOI":"10.1152\/ajprenal.00402.2003","volume":"286","author":"JL Lavoie","year":"2004","unstructured":"Lavoie JL, Lake-Bruse KD, Sigmund CD . Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Am J Physiol Renal Physiol 2004; 286: F965\u2013F971.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFhr201369_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cmet.2011.03.001","volume":"13","author":"SB Gurley","year":"2011","unstructured":"Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, Snouwaert JN, Le TH, McDonough AA, Koller BH, Coffman TM . AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 2011; 13: 469\u2013475.","journal-title":"Cell Metab"},{"key":"BFhr201369_CR35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1074\/jbc.M111.298919","volume":"287","author":"M Mamenko","year":"2012","unstructured":"Mamenko M, Zaika O, Ilatovskaya DV, Staruschenko A, Pochynyuk O . Angiotensin II increases activity of the epithelial Na+ channel (ENaC) in distal nephron additively to aldosterone. J Biol Chem 2012; 287: 660\u2013671.","journal-title":"J Biol Chem"},{"key":"BFhr201369_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/01.HYP.0000196950.48596.21","volume":"47","author":"SH Padia","year":"2006","unstructured":"Padia SH, Howell NL, Siragy HM, Carey RM . Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension 2006; 47: 537\u2013544.","journal-title":"Hypertension"},{"key":"BFhr201369_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1161\/HYPERTENSIONAHA.107.101717","volume":"51","author":"L Gao","year":"2008","unstructured":"Gao L, Wang W, Li H, Sumners C, Zucker IH . Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats. Hypertension 2008; 51: 521\u2013527.","journal-title":"Hypertension"},{"key":"BFhr201369_CR38","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/01.RES.79.2.302","volume":"79","author":"JR Martens","year":"1996","unstructured":"Martens JR, Wang D, Sumners C, Posner P, Gelband CH . Angiotensin II type 2 receptor-mediated regulation of rat neuronal K+ channels. Circ Res 1996; 79: 302\u2013309.","journal-title":"Circ Res"},{"key":"BFhr201369_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/35024095","volume":"407","author":"S AbdAlla","year":"2000","unstructured":"AbdAlla S, Lother H, Quitterer U . AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 2000; 407: 94\u201398.","journal-title":"Nature"},{"key":"BFhr201369_CR40","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nm0901-1003","volume":"7","author":"S AbdAlla","year":"2001","unstructured":"AbdAlla S, Lother H, el Massiery A, Quitterer U . Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001; 7: 1003\u20131009.","journal-title":"Nat Med"},{"key":"BFhr201369_CR41","doi-asserted-by":"publisher","first-page":"28989","DOI":"10.1074\/jbc.M403880200","volume":"279","author":"S Nouet","year":"2004","unstructured":"Nouet S, Amzallag N, Li JM, Louis S, Seitz I, Cui TX, Alleaume AM, Di Benedetto M, Boden C, Masson M, Strosberg AD, Horiuchi M, Couraud PO, Nahmias C . Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 2004; 279: 28989\u201328997.","journal-title":"J Biol Chem"},{"key":"BFhr201369_CR42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ncb1137","volume":"6","author":"Y Zou","year":"2004","unstructured":"Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T, Komuro I . Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 2004; 6: 499\u2013506.","journal-title":"Nat Cell Biol"},{"key":"BFhr201369_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/01.HYP.0000228997.88162.a8","volume":"48","author":"PM Abadir","year":"2006","unstructured":"Abadir PM, Periasamy A, Carey RM, Siragy HM . Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension 2006; 48: 316\u2013322.","journal-title":"Hypertension"},{"key":"BFhr201369_CR44","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/HYPERTENSIONAHA.111.175208","volume":"59","author":"N Yasuda","year":"2012","unstructured":"Yasuda N, Akazawa H, Ito K, Shimizu I, Kudo-Sakamoto Y, Yabumoto C, Yano M, Yamamoto R, Ozasa Y, Minamino T, Naito AT, Oka T, Shiojima I, Tamura K, Umemura S, Paradis P, Nemer M, Komuro I . Agonist-independent constitutive activity of angiotensin II receptor promotes cardiac remodeling in mice. Hypertension 2012; 59: 627\u2013633.","journal-title":"Hypertension"},{"key":"BFhr201369_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-042711-135929","volume":"64","author":"DA Calhoun","year":"2013","unstructured":"Calhoun DA . Hyperaldosteronism as a common cause of resistant hypertension. Annu Rev Med 2013; 64: 233\u2013247.","journal-title":"Annu Rev Med"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201369","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:13:03Z","timestamp":1684429983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFhr201369"],"URL":"https:\/\/doi.org\/10.1038\/hr.2013.69","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}